Laboratory Operating Income Over Time
| LH Stock | USD 289.89 5.39 1.89% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Laboratory Performance and Laboratory Correlation. Laboratory | Build AI portfolio with Laboratory Stock |
Is there potential for Health Care Providers & Services market expansion? Will Laboratory introduce new products? Factors like these will boost the valuation of Laboratory. Expected growth trajectory for Laboratory significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.56 | Dividend Share 2.88 | Earnings Share 10.19 | Revenue Per Share | Quarterly Revenue Growth 0.086 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Laboratory's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Laboratory represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Laboratory's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Laboratory and related stocks such as Waters, Quest Diagnostics, and Zimmer Biomet Holdings Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WAT | 56.4 M | 528.6 M | 511.5 M | 517.3 M | 517.9 M | 567.5 M | 625 M | 662.2 M | 739.8 M | 708.5 M | 645.5 M | 821.7 M | 873.4 M | 817.7 M | 826.4 M | 802.6 M | 492 M |
| DGX | (601.3 M) | 995 M | 1.2 B | 1.5 B | 983 M | 1.4 B | 1.3 B | 1.2 B | 1.1 B | 1.2 B | 2 B | 2.4 B | 1.4 B | 1.3 B | 1.3 B | 1.6 B | 1.1 B |
| ZBH | 211 M | 1 B | 1 B | 1 B | 1 B | 467.3 M | 821.1 M | 799.3 M | 33.8 M | 1.1 B | 83.1 M | 860.3 M | 696.3 M | 1.3 B | 1.3 B | 1.4 B | 861 M |
| WST | 23.5 M | 115.9 M | 136.5 M | 162.4 M | 182 M | 128.6 M | 196.8 M | 228.9 M | 254.8 M | 297.2 M | 419 M | 758.7 M | 763.5 M | 710.9 M | 594.6 M | 683.8 M | 718 M |
| ILMN | (5.9 M) | 199.5 M | 200.8 M | 134.1 M | 514.7 M | 613 M | 587 M | 606 M | 883 M | 985 M | 393 M | (123 M) | (4.2 B) | (1.1 B) | (833 M) | 865 M | 908.2 M |
| DXCM | (4 M) | (44.8 M) | (55.7 M) | (28.9 M) | (21.5 M) | (57.1 M) | (63.9 M) | (42.5 M) | (186.3 M) | 142.3 M | 299.5 M | 265.8 M | 391.2 M | 597.7 M | 600 M | 690 M | 724.5 M |
| STE | 200 K | 222.3 M | 242.8 M | 206.8 M | 227.2 M | 212.9 M | 226.2 M | 399.9 M | 411 M | 537 M | 548.4 M | 477.8 M | 791.1 M | 836.1 M | 866.6 M | 996.6 M | 1 B |
| BIIB | (32.9 M) | 1.7 B | 1.8 B | 2.5 B | 4 B | 4.9 B | 5.2 B | 5.3 B | 5.9 B | 7 B | 4.6 B | 2.8 B | 2.9 B | 2.1 B | 2.5 B | 1.9 B | 1.6 B |
| INCY | (4.9 M) | (143.2 M) | 1.1 M | (16.1 M) | (4.8 M) | 50.7 M | 164 M | (235.7 M) | 155.4 M | 421.7 M | (240.3 M) | 637.5 M | 599.6 M | 651.8 M | 80.1 M | 1.3 B | 1.4 B |
| UTHR | (13.3 M) | 317.8 M | 421.6 M | 292.5 M | 538.8 M | 699 M | 1.1 B | 814.9 M | 805.4 M | (187.6 M) | 593.6 M | 555.9 M | 979.7 M | 1.2 B | 1.4 B | 1.6 B | 1.7 B |
Laboratory and related stocks such as Waters, Quest Diagnostics, and Zimmer Biomet Holdings Operating Income description
Operating Income is the amount of profit realized from Laboratory operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Laboratory of is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Laboratory of | LH |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 531 South Spring |
| Exchange | New York Stock Exchange |
USD 289.89
Check out Laboratory Performance and Laboratory Correlation. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Laboratory technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.